Ovarian cancer risk not affected by alcohol and smoking, but reduced by caffeine

A new study has found that cigarette smoking and alcohol consumption do not have an effect on ovarian cancer risk, while caffeine intake may lower the risk, particularly in women not using hormones. The study is published in the March 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Various studies have assessed the potential link between modifiable factors such as smoking or caffeine and alcohol intake and have generated conflicting results. To help clarify these associations, Dr. Shelley S. Tworoger, of Harvard Medical School and the Harvard School of Public Health, and colleagues examined ongoing questionnaire data from the Brigham and Women’s Hospital-based Nurses’ Health Study, which includes 121,701 US female registered nurses. The Nurses’ Health Study cohort was established in 1976, when women aged 30-35 completed and returned initial questionnaires. Every two years, questionnaires are sent to the women to update exposure variables and document newly diagnosed diseases.

Dr. Tworoger and her co-investigators prospectively examined associations between smoking and ovarian cancer risk among 110,454 women and between alcohol or caffeine and ovarian cancer risk among 80,253 women, all followed between June 1, 1976 and June 1, 2004. For the smoking analyses, they identified 737 confirmed cases of epithelial ovarian cancer, and for the dietary analyses, they identified 507 cases.

There was no association between current or past smoking and ovarian cancer risk, however smoking status, duration, and pack-years were significantly associated with risk of mucinous tumors, a rare form of ovarian cancer. The authors also found no association between alcohol consumption and ovarian cancer risk. However they observed an inverse trend of risk with total caffeine and caffeinated coffee intake, but no association with decaffeinated coffee. The potential reduction in risk with higher caffeine intake appeared to be strongest for women who had never used oral contraceptives or postmenopausal hormones.

The authors concluded that “reducing alcohol intake and cessation of smoking is not likely to have a substantial impact on risk of ovarian cancer.” They add that “the possibility that caffeine may reduce ovarian cancer risk, particularly for women who have not previously used exogenous hormones, is intriguing and warrants further study, including an evaluation of possible biological mechanisms.”

Source: Wiley-Blackwell

Related stories:

Mechanisms of cardiovascular disease and cancer give clues to new therapies
Cardiovascular conditions leading to heart attacks and strokes are treated quite separately from common cancers of the prostate, breast or lung, but now turn out to involve some of the same critical mechanisms at the molecular level. This in turn provides clues to more effective therapies for both cancer and cardiovascular diseases, but requires researchers in these distinct fields to come together. The seeds were sown for closer cooperation between these two groups at a recent workshop organised by the European Science Foundation (ESF), which also highlighted the striking progress already made in understanding key common mechanisms underlying both disease categories.
European patent office restores breast cancer gene patent
The European Patent Office on Wednesday restored on appeal a controversial patent for a breast cancer gene that had been withdrawn from a US biotech firm, but granting it in a more restricted form than before.
Genetic test can reveal a painful truth
Wanda Stutsman was 32 years old and seven months pregnant when she began her first round of chemotherapy.
Birth control has long-term effect on hormone exposure
Researchers at Wake Forest University School of Medicine may be one step closer to understanding why past oral contraceptive use dramatically lowers the risk of ovarian and uterine cancers later in life.
New approach to genetic testing could halve deaths from inherited bowel cancer
Changing the approach to genetic screening for cancers in Australia could effectively halve deaths caused by an inherited form of bowel cancer, says a University of Melbourne expert.
Ovarian cancer test is under fire
OvaSure, the much bally­hooed new diagnostic blood test for early detection of ovarian cancer, is still causing much consternation.
Risk of breast cancer mutations underestimated for Asian women, study shows
Oncologist Allison Kurian, MD, and her colleagues at the Stanford University School of Medicine were perplexed. Computer models designed to identify women who might have dangerous genetic mutations that increase their risk of breast and ovarian cancer worked well for white women. But they seemed to be less reliable for another ethnic group.
Landmark study reports breakdown in biotech patent system
The world's intellectual property system is broken. It's stopping lifesaving technologies from reaching the people who need them most in developed and developing countries, according to the authors of a report released in Ottawa today by an international coalition of experts.

News discussion:

Medicine & Health news